A telehealth company that sells a compounded version of medications used for weight loss has found itself at the center of an escalating controversy over an advertisement that aired during the 2025 ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site. The ad also hit a nerve with the pharma industry, lawmakers and some industry groups. The ad, called "Sick ...

Hims & Hers has capitalized on the outsize consumer demand for obesity drugs. (Hims & Hers Health) Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom ...

Hims & Hers’ 2025 Super Bowl commercial generated plenty of conversation—and controversy—leading up to the big game. It took aim at the American weight loss industry, including Big Pharma makers of ...

A Super Bowl ad touting Hims & Hers Health Inc.’s copycat weight-loss drugs is getting pushback from the branded drugmakers’ lobbying group, which says it’s “misleading” and potentially violates ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Hims & Hers sells a compounded weight loss medication. A telehealth company that sells a compounded version of medications used for weight loss has found itself at the center of an escalating ...